drugset / Trial / NCT00967642
Intravenous Insulin in Patients With Diabetes After Percutaneous Coronary Intervention (PCI)
Terminated
70 enrolled
Hospital de Clinicas de Porto Alegre
Conselho Nacional de Desenvolvimento Científico e Tecnológico · collabFIPE · collabFundação de Amparo à Pesquisa do Estado do Rio Grande do Sul, Brazil · collab
RandomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the effects of intravenous insulin/24 hours to normalize glycemia upon markers of oxidative stress (protein oxidation and total antioxidant defense) and inflammation (C-reactive protein (CRP) and sCD40L) in diabetic patients submitted to PCI with stent.
Timeline
- Start
- 2006-08
- Primary completion
- 2008-07
- Completion
- 2009-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Insulin | Protein / enzyme biologic | — | Intravenous |